These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 12784708)

  • 1. [Primary and secondary prevention of coronary artery disease].
    Mohri M
    Fukuoka Igaku Zasshi; 2003 Mar; 94(3):43-7. PubMed ID: 12784708
    [No Abstract]   [Full Text] [Related]  

  • 2. [Coronary artery disease in patients with diabetes mellitus and its treatment].
    Teramoto T
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():94-9. PubMed ID: 11989270
    [No Abstract]   [Full Text] [Related]  

  • 3. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.
    ; ; ; Smith SC; Allen J; Blair SN; Bonow RO; Brass LM; Fonarow GC; Grundy SM; Hiratzka L; Jones D; Krumholz HM; Mosca L; Pearson T; Pfeffer MA; Taubert KA
    J Am Coll Cardiol; 2006 May; 47(10):2130-9. PubMed ID: 16697342
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of coronary artery disease in a patient with adult-onset diabetes mellitus].
    Syvänne M
    Duodecim; 1999; 115(10):1167-73. PubMed ID: 11877856
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metabolic syndrome as a coronary risk factor. Prevention and treatment].
    Kłosiewicz-Latoszek L; Cybulska B
    Kardiol Pol; 2003 Jul; 59(7):59-65. PubMed ID: 14560351
    [No Abstract]   [Full Text] [Related]  

  • 6. [Primary prevention of stroke. What helps--what does not help? The guidelines of the German Society of Neurology briefly summarized].
    Diener HC
    MMW Fortschr Med; 2003; 145 Suppl 1():9-10. PubMed ID: 12958797
    [No Abstract]   [Full Text] [Related]  

  • 7. Secondary prevention of coronary artery disease.
    Hall SL; Lorenc T
    Am Fam Physician; 2010 Feb; 81(3):289-96. PubMed ID: 20112887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secondary prevention of ischemic cardiopathy].
    Caruzzo E; Caruzzo C
    Cardiologia; 1995 May; 40(5):347-53. PubMed ID: 8529246
    [No Abstract]   [Full Text] [Related]  

  • 9. [Secondary prevention of coronary heart disease. How effective are modern therapy methods?].
    Kolenda KD
    Dtsch Med Wochenschr; 2003 Sep; 128(36):1849-53. PubMed ID: 12964107
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antihypertensive therapy: risk stratification in diabetes and cardiac diseases].
    Baumgart P
    MMW Fortschr Med; 2006 Mar; 148(11):57, 59-60. PubMed ID: 16612965
    [No Abstract]   [Full Text] [Related]  

  • 11. Office management after myocardial infarction.
    Aronow WS
    Am J Med; 2010 Jul; 123(7):593-5. PubMed ID: 20609678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.
    Smith SC; Allen J; Blair SN; Bonow RO; Brass LM; Fonarow GC; Grundy SM; Hiratzka L; Jones D; Krumholz HM; Mosca L; Pasternak RC; Pearson T; Pfeffer MA; Taubert KA; ;
    Circulation; 2006 May; 113(19):2363-72. PubMed ID: 16702489
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secondary prevention after an acute myocardial infarct. Adrenergic beta-blockers, angiotensin-converting enzyme inhibitors and statins for everyone?].
    Morais J
    Rev Port Cardiol; 2000 Jan; 19(1):99-105. PubMed ID: 10731795
    [No Abstract]   [Full Text] [Related]  

  • 16. [Classification and risk stratification in hypertension Recommendations of the European Society for Hypertension (ESH)].
    Zidek W
    MMW Fortschr Med; 2003 Nov; 145(45):41-2. PubMed ID: 14699807
    [No Abstract]   [Full Text] [Related]  

  • 17. [The secondary prevention of coronary disease: ACE inhibitors, adrenergic beta-blockers and statins for everyone? The arguments con].
    Simões L; Guimarães J; Fontes JP
    Rev Port Cardiol; 2000 Jan; 19(1):107-13. PubMed ID: 10731796
    [No Abstract]   [Full Text] [Related]  

  • 18. [Secondary prevention after myocardial infarction].
    Czuriga I
    Orv Hetil; 2002 Sep; 143(37):2117-28. PubMed ID: 12434627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary prevention of coronary artery disease in urban Indian primary care.
    Gupta R
    Int J Cardiol; 2009 Jun; 135(2):184-6. PubMed ID: 18620762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of dyslipidemia in the secondary prevention of coronary artery disease].
    Syvänne M
    Duodecim; 1998; 114(15):1503-8. PubMed ID: 11552239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.